A new study led by investigators from Mass General Brigham trialed stereotactic (targeted) brain-directed radiation in 100 ...

The fluorescent labeling compound—dubbed "Sialyl Lewis Yellow"—was developed by an international team led from the Pohang University of Science and Technology in South Korea. It works by binding to ...

Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the ...

Studies show in mice show that targeting the metabolic pathways could inhibit the growth of melanoma and combining this ...

Could a legendary tomb curse become a medical miracle? Scientists may have reengineered Aspergillus flavus, linked to King ...

In a bid to better understand how cancer cells power their explosive growth and spread, scientists at Johns Hopkins Medicine ...

The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

The Chan Zuckerberg Initiative (CZI) reports its latest AI model aimed at helping researchers better understand how cells ...

In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...

Cancer cells are different to normal cells in various ways. Cancer cells don't stop growing and dividing. Unlike normal cells, cancer cells don't stop growing and dividing when there are enough of ...

Not everyone has cancer cells in their body, but they may develop due to different factors such as genetics, exposure to certain environments, and lifestyle choices. The body has a natural ability ...

Scientists at UC San Francisco have engineered T-cells to produce a potent anti-cancer cytokine, but only when they encounter tumor cells. The immunotherapy eliminated melanoma and pancreatic cancer ...